Telling the truth about SME life today

Hot 100 2014 – 17: Flynn Pharma

Share on facebook
Share on twitter
Share on linkedin
Share on email

Flynn Pharma

Latest turnover: 54,088,000
Three-year compound growth rate (%): 56.05
Latest EBITDA: £13,238,871

Established in Ireland in 1994, Flynn Pharma is a specialistpharmaceutical company focused on acquiring and commercialising branded products in secondary healthcare markets. The company was initially responsible for the distribution of a number of barbiturate products.

Since then, Flynn has acquired a range of oral and injectable antibiotics from Eli Lilly & Co and even created a hospital sales force and launched a Medikinet range for the treatment of ADHD.

In 2012, Flynn Pharma became the UK partner of Innocoll for the marketing and distribution of the CollaGUARD adhesion barrier.

The company says its goal is “to be the foremost European provider [?] in the underserved therapeutic categories.”

16: Domestic & General

18: Maindec Computer Solutions

Trending

Topic

Share on facebook
Share on twitter
Share on linkedin
Share on email

Related Stories

More From

Trending

If you enjoyed this article,
why not join our newsletter?

We promise only quality content, tailored to suit what our readers like to see!